The National Institute on Minority Health and Health Disparities (NIMHD) and the National Human Genome Research Institute (NHGRI) are soliciting administrative supplements to support collection and/or analysis of data from Native Hawaiian and Other Pacific Islander (NH/OPI) populations, who represent one of NIH’s designated health disparity populations.
Based on the Office of Management and Budget (OMB) classification, “Native Hawaiian or Other Pacific Islander” refers to a person residing in the US having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. For this Notice, NH/OPI populations of specific interest include Native Hawaiians, individuals with origins in the US-Affiliated Pacific Islands (American Samoa, Guam, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau), and individuals with origins in Fiji or Tonga, as these groups have the highest representation in the US.
Existing data indicate that NH/OPI populations have higher prevalence of and/or poorer outcomes for a variety of health conditions, including obesity, diabetes, cardiovascular disease, chronic lower respiratory disease, cancer, infant mortality, depression, and HIV/AIDS, as well as a shorter life expectancy. However, in many available studies or datasets, NH/OPI populations are absent, included in numbers too small to include in subpopulation analysis, combined with Asians, or placed into the heterogeneous category of “Other.” More research is needed using disaggregated data, including NH/OPIs separated from other racial/ethnic groups, as well as differentiation of subpopulations under the NH/OPI umbrella, to better understand the health status and needs of NH/OPI populations and address health disparities.
Appropriate research activities include, but are not limited to the following:
- Enrollment of NH/OPI populations in primary data collection studies to increase sample size to allow for adequately powered subgroup analysis. This may include increasing sample size of NH/OPI samples overall or for specific subgroups (e.g., Samoans). Primary data collection may only occur in the US (including the US Affiliated Pacific Islands).
- Pooling of data from the parent award with other studies or datasets to increase sample size for valid subgroup analysis and/or cross-study comparisons.
- Using publicly available data to conduct comparative analysis with study data, and/or to link with study data (e.g., neighborhood-level characteristics) to conduct multi-level analysis. Examples of publicly available data include US Census Data, the American Community Survey, the Native Hawaiian/Pacific Islander National Health Interview Survey, or Medicaid/Medicare claims data.
Areas of specific interest include but are not limited to the following:
- Comparisons between NH/OPI populations and other racial/ethnic groups related to study variables or outcomes, such as patterns of disease risk, resilience, morbidity, and mortality; healthcare utilization and outcomes; or intervention effectiveness.
- Examination of variation on study variables or outcomes within NH/OPI populations, including different population subgroups (e.g., Tongans compared to Fijians) or geographic distribution (e.g., Chamorros residing in Guam vs. the US mainland, NH/OPI populations living in the Western vs. Southern region of the US).
- Projects using public use or restricted data from the 2014 Native Hawaiian Pacific Islander National Health Interview Survey (NHPI NHIS), are also encouraged.
Administrative supplement requests are due July 15, 2019.